# Chattem Inc - Inspection Records

Source: https://www.keypedia.com/companies/chattem-inc/4ca90cd8-88ca-4db8-ad0b-98e339ee0c0a

> Inspection records and compliance data for Chattem Inc in Chattanooga, Tennessee. Access full analysis and detailed observations.

---

## Details

- Name: Chattem Inc
- FEI Number: 1022556
- City: Chattanooga
- State: Tennessee
- Country Name: United States
- Address Line 1: 1715 W 38th St
- Zip Code: 37409

## Related Documents

- [483 - Chattem Inc - 2025-08-22](https://www.keypedia.com/records/483/chattem-inc/1124d97e-d527-4a8b-800b-aaadf01694c4) — source: FDA, date: August 22, 2025
- [483 - Chattem Inc - 2025-08-22](https://www.keypedia.com/records/483/chattem-inc/15050091-b049-4522-8c16-d1d10d68b3d3) — source: FDA, date: August 22, 2025
- [FDA Inspection 1252094 - Chattem Inc - 2025-08-22](https://www.keypedia.com/records/fda_inspections/chattem-inc/bed12ef7-2891-4d56-9205-bed47d877e3a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 22, 2025
- [FDA Inspection 1208887 - Chattem Inc - 2023-06-13](https://www.keypedia.com/records/fda_inspections/chattem-inc/e8888734-30f0-458e-911c-f87aff4fbb74) — classification: No Action Indicated (NAI), source: FDA, date: June 13, 2023
- [EIR - Chattem Inc - 2020-03-13](https://www.keypedia.com/records/eir/chattem-inc/c548f149-4105-48e5-bcbb-e962b6aa5d78) — source: FDA, date: March 13, 2020
- [483 - Chattem Inc - 2020-03-13](https://www.keypedia.com/records/483/chattem-inc/0647991c-0755-48a7-8806-17e1c3e38c5f) — source: FDA, date: March 13, 2020
- [FDA Inspection 1120793 - Chattem Inc - 2020-03-13](https://www.keypedia.com/records/fda_inspections/chattem-inc/88454c82-7f5f-4b3d-bf67-1e2bb8b4037d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 13, 2020
- [FDA Inspection 1017661 - Chattem Inc - 2017-05-04](https://www.keypedia.com/records/fda_inspections/chattem-inc/c6d0c86b-84ea-4481-baa8-ef7e1e1d0184) — classification: No Action Indicated (NAI), source: FDA, date: May 4, 2017
- [FDA Inspection 1006624 - Chattem Inc - 2017-03-02](https://www.keypedia.com/records/fda_inspections/chattem-inc/35d1a843-2ebd-42d7-88b2-eb44084a535f) — classification: No Action Indicated (NAI), source: FDA, date: March 2, 2017
- [FDA Inspection 984987 - Chattem Inc - 2016-09-02](https://www.keypedia.com/records/fda_inspections/chattem-inc/a07c4672-0584-4ca5-b13f-3aaf112e4913) — classification: No Action Indicated (NAI), source: FDA, date: September 2, 2016
- [FDA Inspection 870405 - Chattem Inc - 2014-03-14](https://www.keypedia.com/records/fda_inspections/chattem-inc/beb80ae2-3c43-4eec-8e6c-0f5645e7025a) — classification: No Action Indicated (NAI), source: FDA, date: March 14, 2014
- [FDA Inspection 840161 - Chattem Inc - 2013-07-12](https://www.keypedia.com/records/fda_inspections/chattem-inc/4d9e406b-e530-4ad8-be44-4b17e113cb85) — classification: No Action Indicated (NAI), source: FDA, date: July 12, 2013
- [FDA Inspection 769263 - Chattem Inc - 2012-02-24](https://www.keypedia.com/records/fda_inspections/chattem-inc/e0166c75-24b0-4238-b231-3faef78d9e30) — classification: No Action Indicated (NAI), source: FDA, date: February 24, 2012
- [FDA Inspection 611696 - Chattem Inc - 2009-09-04](https://www.keypedia.com/records/fda_inspections/chattem-inc/5f67f67c-7083-4030-9154-42166e84e3af) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 4, 2009

## Related Companies

- [Amphastar Pharmaceuticals, Inc.](https://www.keypedia.com/companies/amphastar-pharmaceuticals-inc/e90eb882-5679-4c85-bbc8-f69ca69cc537)
- [Catalent CTS, LLC](https://www.keypedia.com/companies/catalent-cts-llc/db17ec22-68a4-42be-86e9-4c1410a493a8)
- [Ultradent Products, Inc.](https://www.keypedia.com/companies/ultradent-products-inc/16b4d8af-54bd-48d3-acc8-a5169bd5bfe3)
- [Catalent Pharma Solutions, LLC](https://www.keypedia.com/companies/catalent-pharma-solutions-llc/12f42026-6a34-4cfe-936d-3646a0e34c8d)
- [Lyne Laboratories, Inc.](https://www.keypedia.com/companies/lyne-laboratories-inc/47a79cbe-dd2e-43d9-bf70-129caae3817c)
- [Abraxis Bioscience, LLC](https://www.keypedia.com/companies/abraxis-bioscience-llc/5751a531-276f-4635-9289-30cacf498d86)
- [DPT Laboratories, Ltd](https://www.keypedia.com/companies/dpt-laboratories-ltd/0a6b4d0a-ad7e-4f4f-ab10-34e0ef9913d4)
- [Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company](https://www.keypedia.com/companies/bristol-myers-squibb-holdings-pharma-ltd-liability-company/64a65e7b-7328-491c-8b08-cc8f2e018968)
- [Bushu Pharmaceuticals Ltd.](https://www.keypedia.com/companies/bushu-pharmaceuticals-ltd/f3ccab51-b6fa-4873-b2de-61ba32d7967e)
- [Laboratorios Liconsa SAU](https://www.keypedia.com/companies/laboratorios-liconsa-sau/ab88a2bb-8c52-445d-8417-82ea8f48bdf6)

## Related Officers

- [investigator](https://www.keypedia.com/people/tracy-j-washington/c7e1e89d-3ed9-44af-b6af-a43d084e7fb9)
- [recipient](https://www.keypedia.com/people/roy-a-hibbs/63447f4f-91df-4754-80de-24938755e4f1)
- [company_representative](https://www.keypedia.com/people/jennifer-palmer/707777bc-db75-46ff-b6cf-d8ffa9f288b6)
- [Jeffrey T. Prosterman](https://www.keypedia.com/people/jeffrey-t-prosterman/1343bea3-692d-484e-b29f-c9f8f052f09c)
- [Thuy Tram L. Nguyen](https://www.keypedia.com/people/thuy-tram-l-nguyen/b58f2445-728e-4f79-b7eb-4dfb7e982e25)